07Jan/13

Research and Markets: Biogen-Idec's and Facet Biotech's Daclizumab: Can It … – Fort Mills Times

Research and Markets: Biogen-Idec’s and Facet Biotech’s Daclizumab: Can It
Fort Mills Times
Daclizumab is the active agent in Zenapax (Roche), a humanized antibody that blocks the IL-2 receptor. It was first approved in 1997 for transplant rejection prevention. A phase II study in multiple sclerosis (MS) showed evidence of activity and an

07Jan/13

Full Force's Bowlegged Lou Tells of His Brother Paul Anthony's Stem Cell … – Eurweb.com


Eurweb.com

Full Force’s Bowlegged Lou Tells of His Brother Paul Anthony’s Stem Cell
Eurweb.com
The bone marrow stem cell transplant between Paul & myself went well. That’s the 1st phase as we ain’t through yet. We must keep sending prayers for Paul’s brand-Lou immune system, oops did I say brand-Lou? I meant brand new. 😮 ) His brand new